SLC5A5 and neoplasm: To expand our strategies to include local as well as temporal control of NIS transgene induction and enhanced tumor selectivity of MSC-mediated NIS gene therapy, we engineered MSCs to express the NIS gene under control of a heat-inducible HSP70B promoter (HSP70B-NIS-MSCs).